Pinnacle Associates LTD Intercept Pharmaceuticals, Inc. Transaction History

Pinnacle Associates LTD

$6.17 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$9.99 - $18.71 $28,791 - $53,922	-2,882 Reduced 1.44%	197,237 $3.66 Million
Q2 2023 Jul 26, 2023	SELL	$9.17 - $19.29 $79,595 - $167,437	-8,680 Reduced 4.16%	200,119 $2.21 Million
Q1 2023 May 04, 2023	BUY	$12.53 - $21.71 $19,120 - $33,129	1,526 Added 0.74%	208,799 $2.8 Million
Q4 2022 Jan 31, 2023	SELL	$11.61 - $16.11 $77,670 - $107,775	-6,690 Reduced 3.13%	207,273 $2.56 Million
Q4 2022 Jan 25, 2023	BUY	$11.61 - $16.11 $16,428 - $22,795	1,415 Added 0.67%	213,963 $0

Q3 2022 Oct 31, 2022	BUY	$12.21 - $19.7 $1.21 Million - $1.95 Million	98,778 Added 86.82%	212,548 $2.97 Million
Q2 2022 Aug 02, 2022	SELL	$11.23 - $19.59 $8,130 - $14,183	-724 Reduced 0.63%	113,770 $1.57 Million
Q1 2022 May 05, 2022	SELL	$13.37 - $17.79 $54,950 - $73,116	-4,110 Reduced 3.47%	114,494 $1.86 Million
Q4 2021 Feb 02, 2022	SELL	$14.28 - $19.53 $31,430 - $42,985	-2,201 Reduced 1.82%	118,604 $1.93 Million
Q3 2021 Oct 19, 2021	SELL	$12.99 - $20.47 $27,993 - $44,112	-2,155 Reduced 1.75%	120,805 $1.79 Million
Q2 2021 Aug 02, 2021	BUY	$15.46 - $24.5 $42,391 - $67,179	2,742 Added 2.28%	122,960 $2.46 Million
Q1 2021 May 12, 2021	SELL	$19.33 - $37.75 $263,081 - $513,777	-13,610 Reduced 10.17%	120,218 $2.78 Million
Q4 2020 Jan 26, 2021	SELL	$24.48 - $42.47 $215,032 - $373,056	-8,784 Reduced 6.16%	133,828 $3.31 Million
Q3 2020 Oct 23, 2020	SELL	$39.09 - $53.44 $204,049 - $278,956	-5,220 Reduced 3.53%	142,612 $5.91 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $120,486 - $237,463	-2,580 Reduced 1.72%	147,832 $7.08 Million
Q1 2020 May 13, 2020	SELL	$48.35 - $118.68 $1.15 Million - $2.83 Million	-23,881 Reduced 13.7%	150,412 $9.47 Million
Q4 2019 Feb 03, 2020	SELL	$57.36 - $124.1 $969,097 - $2.1 Million	-16,895 Reduced 8.84%	174,293 $21.6 Million
Q3 2019 Nov 08, 2019	BUY	$58.69 - $80.46 $3.6 Million - $4.94 Million	61,373 Added 47.28%	191,188 $12.7 Million
Q2 2019 Aug 05, 2019	SELL	$77.77 - $120.68 $962,248 - $1.49 Million	-12,373 Reduced 8.7%	129,815 $10.3 Million
Q1 2019 May 10, 2019	SELL	$91.83 - $120.68 $374,666 - $492,374	-4,080 Reduced 2.79%	142,188 $15.9 Million
Q4 2018 Feb 05, 2019	SELL	$85.79 - $126.46 $608,251 - $896,601	-7,090 Reduced 4.62%	146,268 $14.7 Million
Q3 2018 Nov 13, 2018	SELL	$88.49 - $127.55 $2.15 Million - $3.1 Million	-24,277 Reduced 13.67%	153,358 $19.4 Million
Q2 2018 Aug 08, 2018	SELL	$60.0 - $85.67 $1.73 Million - $2.47 Million	-28,795 Reduced 13.95%	177,635 $14.9 Million
Q1 2018 May 11, 2018	SELL	$52.72 - $67.25 $467,099 - $595,835	-8,860 Reduced 4.12%	206,430 $12.7 Million
Q4 2017 Feb 12, 2018	BUY	$58.2 - $72.76 $12.5 Million - $15.7 Million	215,290	215,290 $12.6 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account